12 results on '"Mačiulaitis, Romaldas"'
Search Results
2. Drugs with a negative impact on cognitive functions (part 3): antibacterial agents in patients with chronic kidney disease.
- Author
-
Liabeuf, Sophie, Hafez, Gaye, Pešić, Vesna, Spasovski, Goce, Bobot, Mickaël, Mačiulaitis, Romaldas, Bumblyte, Inga Arune, Ferreira, Ana Carina, Farinha, Ana, Malyszko, Jolanta, Pépin, Marion, Massy, Ziad A, Unwin, Robert, Capasso, Giovambattista, Mani, Laila-Yasmin, and Target), CONNECT Action (Cognitive Decline in Nephro-Neurology European Cooperative
- Subjects
DRUG side effects ,DRUG utilization ,DRUG monitoring ,CHRONIC kidney failure ,CENTRAL nervous system - Abstract
The relationship between chronic kidney disease (CKD) and cognitive function has received increased attention in recent years. Antibacterial agents (ABs) represent a critical component of therapy regimens in patients with CKD due to increased susceptibility to infections. Following our reviewing work on the neurocognitive impact of long-term medications in patients with CKD, we propose to focus on AB-induced direct and indirect consequences on cognitive function. Patients with CKD are predisposed to adverse drug reactions (ADRs) due to altered drug pharmacokinetics, glomerular filtration decline, and the potential disruption of the blood–brain barrier. ABs have been identified as a major cause of ADRs in vulnerable patient populations. This review examines the direct neurotoxic effects of AB classes (e.g. beta-lactams, fluoroquinolones, aminoglycosides, and metronidazole) on the central nervous system (CNS) in patients with CKD. We will mainly focus on the acute effects on the CNS associated with AB since they are the most extensively studied effects in CKD patients. Moreover, the review describes the modulation of the gut microbiota by ABs, potentially influencing CNS symptoms. The intricate brain–gut–kidney axis emerges as a pivotal focus, revealing the interplay between microbiota alterations induced by ABs and CNS manifestations in patients with CKD. The prevalence of antibiotic-associated encephalopathy in patients with CKD undergoing intravenous AB therapy supports the use of therapeutic drug monitoring for ABs to reduce the number and seriousness of ADRs in this patient population. In conclusion, elucidating AB-induced cognitive effects in patients with CKD demands a comprehensive understanding and tailored therapeutic strategies that account for altered pharmacokinetics and the brain–gut–kidney axis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies
- Author
-
Appel, Lawrence J, Greene, Tom, Chen, Teresa K, Chalmers, John, Arima, Hisatomi, Perkovic, Vlado, Levin, Adeera, Djurdjev, Ognjenka, Tang, Mila, Nally, Joseph, Navaneethan, Sankar D, Schold, Jesse D, Weldegiorgis, Misghina, Herrington, William G, Smith, Margaret, Hsu, C Yenchih, Hwang, Shih-Jen, Chang, Alex R, Kirchner, H. Lester, Green, Jamie A, Ho, Kevin, Marks, Angharad, Prescott, Gordon, Clark, Laura E, Fluck, Nick, Shalev, Varda, Chodick, Gabriel, Blankestijn, Peter J, Van Zuilen, Arjan, Van den Brand, Jan A, Sarnak, Mark J, Bottinger, Erwin, Nadkarni, Girish N, Ellis, Stephen G, Nadukuru, Rajiv, Metzger, Marie, Flamant, Martin, Houillier, Pascal, Haymann, Jean-Philippe, Froissart, Marc, Kenealy, Timothy, Elley, Raina C, Collins, John F, Drury, Paul L, Cuddeback, John K, Ciemins, Elizabeth L, Stempniewicz, Rich, Nelson, Robert G, Knowler, William C, Bakker, Stephen J, Major, Rupert W, Medcalf, James F, Shepherd, David, Barrett-Connor, Elizabeth, Bergstrom, Jaclyn, Ix, Joachim H, Molnar, Miklos Z, Sumida, Keiichi, de Zeeuw, Dick, Brenner, Barry, Qureshi, Abdul R, Elinder, Carl-Gustaf, Runesson, Bjorn, Evans, Marie, Segelmark, Marten, Stendahl, Maria, Schön, Staffan, Naimark, David M, Tangri, Navdeep, Sud, Maneesh, Hirayama, Atsushi, Ichikawa, Kazunobu, Bilo, Henk JG, Landman, Gijs WD, Van Hateren, Kornelis JJ, Kleefstra, Nanne, Hallan, Stein I, Ballew, Shoshana H, Chen, Jingsha, Kwak, Lucia, Surapaneni, Aditya, Parving, Hans-Henrik, Rodby, Roger A., Rohde, Richard D, Lewis, Julia B, Lewis, Edmund, Perrone, Ronald D, Abebe, Kaleab Z, Hou, Fan F, Xie, Di, Hunsicker, Lawrence G, Imai, Enyu, Kobayashi, Fumiaki, Makino, Hirofumi, Ito, Sadayoshi, Remuzzi, Giuseppe, Ruggenenti, Piero, Eckardt, Kai-Uwe, Gudmundsdottir, Hrefna, Maciulaitis, Romaldas, Manley, Tom, Smith, Kimberly, Stockbridge, Norman, Thompson, Aliza, Vetter, Thorsten, Willis, Kerry, Zhang, Luxia, Coresh, Josef, Heerspink, Hiddo J L, Sang, Yingying, Matsushita, Kunihiro, Arnlov, Johan, Astor, Brad C, Black, Corri, Brunskill, Nigel J, Carrero, Juan-Jesus, Feldman, Harold I, Fox, Caroline S, Inker, Lesley A, Ishani, Areef, Jassal, Simerjot, Konta, Tsuneo, Polkinghorne, Kevan, Romundstad, Solfrid, Solbu, Marit D, Stempniewicz, Nikita, Stengel, Benedicte, Tonelli, Marcello, Umesawa, Mitsumasa, Waikar, Sushrut S, Wen, Chi-Pang, Wetzels, Jack F M, Woodward, Mark, Grams, Morgan E, Kovesdy, Csaba P, Levey, Andrew S, and Gansevoort, Ron T
- Published
- 2019
- Full Text
- View/download PDF
4. Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease—Improving Global Outcomes (KDIGO) Controversies Conference
- Author
-
Abu-Alfa, Ali, Archdeacon, Patrick, Block, Geoffrey A., Caskey, Fergus J., Cheung, Alfred K., Cooper, Bruce, Craig, Jonathan C., Dember, Laura M., Eknoyan, Garabed, Gansevoort, Ron T., Gill, John S., Gillespie, Barbara, Greene, Tom, Harris, David C., Haynes, Richard, Hemmelgarn, Brenda R., Herzog, Charles A., Hiemstra, Thomas F., Inker, Lesley A., Jardine, Meg J., Jha, Vivekanand, Jiang, Lixin, Johansen, Kirsten L., Kewalramani, Reshma, Lambers Heerspink, Hiddo J., Lefkowitz, Martin, Lok, Charmaine E., Loud, Fiona, Mačiulaitis, Romaldas, Maddux, Dugan W., Maddux, Franklin W., Madero, Magdalena, Mariz, Segundo, Mauer, Michael, Nally, Joseph V., Jr., Nangaku, Masaomi, Okpechi, Ikechi G., Parfrey, Patrick S., Pecoits-Filho, Roberto, Pereira, Brian J.G., Rocco, Michael V., Rossignol, Patrick, Schaefer, Franz, Tentori, Francesca, Thompson, Aliza, Tonelli, Marcello, Tong, Allison, Toto, Robert D., Tuttle, Katherine R., Vetter, Thorsten, Moon Wang, Angela Yee, Zannad, Faiez, Baigent, Colin, Herrington, William G., Coresh, Josef, Landray, Martin J., Levin, Adeera, Perkovic, Vlado, Pfeffer, Marc A., Rossing, Peter, Walsh, Michael, Wanner, Christoph, Wheeler, David C., Winkelmayer, Wolfgang C., and McMurray, John J.V.
- Published
- 2017
- Full Text
- View/download PDF
5. Characterization of tissue engineered cartilage products: Recent developments in advanced therapy
- Author
-
Mačiulaitis, Justinas, Rekštytė, Sima, Ūsas, Arvydas, Jankauskaitė, Virginija, Gudas, Rimtautas, Malinauskas, Mangirdas, and Mačiulaitis, Romaldas
- Published
- 2016
- Full Text
- View/download PDF
6. Regenerative pharmacology for the treatment of acute kidney injury: Skeletal muscle stem/progenitor cells for renal regeneration?
- Author
-
Pavyde, Egle, Usas, Arvydas, and Maciulaitis, Romaldas
- Published
- 2016
- Full Text
- View/download PDF
7. Human Placental Mesenchymal Stem Cells and Derived Extracellular Vesicles Ameliorate Lung Injury in Acute Respiratory Distress Syndrome Murine Model.
- Author
-
Valiukevičius, Paulius, Mačiulaitis, Justinas, Pangonytė, Dalia, Siratavičiūtė, Vitalija, Kluszczyńska, Katarzyna, Kuzaitytė, Ugnė, Insodaitė, Rūta, Čiapienė, Ieva, Grigalevičiūtė, Ramunė, Zigmantaitė, Vilma, Vitkauskienė, Astra, and Mačiulaitis, Romaldas
- Subjects
LUNGS ,ADULT respiratory distress syndrome ,MESENCHYMAL stem cells ,EXTRACELLULAR vesicles ,LUNG injuries ,PLACENTA - Abstract
This study investigates the therapeutic potential of human placental mesenchymal stem cells (P-MSCs) and their extracellular vesicles (EVs) in a murine model of acute respiratory distress syndrome (ARDS), a condition with growing relevance due to its association with severe COVID-19. We induced ARDS-like lung injury in mice using intranasal LPS instillation and evaluated histological changes, neutrophil accumulation via immunohistochemistry, bronchoalveolar lavage fluid cell count, total protein, and cytokine concentration, as well as lung gene expression changes at three time points: 24, 72, and 168 h. We found that both P-MSCs and EV treatments reduced the histological evidence of lung injury, decreased neutrophil infiltration, and improved alveolar barrier integrity. Analyses of cytokines and gene expression revealed that both treatments accelerated inflammation resolution in lung tissue. Biodistribution studies indicated negligible cell engraftment, suggesting that intraperitoneal P-MSC therapy functions mostly through soluble factors. Overall, both P-MSC and EV therapy ameliorated LPS-induced lung injury. Notably, at the tested dose, EV therapy was more effective than P-MSCs in reducing most aspects of lung injury. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
8. Risk of tumorigenicity in mesenchymal stromal cell–based therapies—Bridging scientific observations and regulatory viewpoints
- Author
-
Barkholt, Lisbeth, Flory, Egbert, Jekerle, Veronika, Lucas-Samuel, Sophie, Ahnert, Peter, Bisset, Louise, Büscher, Dirk, Fibbe, Willem, Foussat, Arnaud, Kwa, Marcel, Lantz, Olivier, Mačiulaitis, Romaldas, Palomäki, Tiina, Schneider, Christian K., Sensebé, Luc, Tachdjian, Gérard, Tarte, Karin, Tosca, Lucie, and Salmikangas, Paula
- Published
- 2013
- Full Text
- View/download PDF
9. EurOP2E – the European Open Platform for Prescribing Education, a consensus study among clinical pharmacology and therapeutics teachers.
- Author
-
Bakkum, Michiel J., Richir, Milan C., Papaioannidou, Paraskevi, Likic, Robert, Sanz, Emilio J., Christiaens, Thierry, Costa, João N., Mačiulaitis, Romaldas, Dima, Lorena, Coleman, Jamie, Tichelaar, Jelle, van Agtmael, Michiel A., for the Education Working Group of the European Association for Clinical Pharmacology and Therapeutics (EACPT) and its affiliated Network of Teachers in Pharmacotherapy (NOTIP), Atanasova, Ivanka, Ganeva, Maria, Gatchev, Emil, Kostadinova, I.I., Matanovic, S. Mimica, Vitezic, D., and Wozniak, Greta
- Subjects
CONSENSUS (Social sciences) ,TEACHING methods ,PHARMACY education ,DIGITAL technology ,PHARMACOLOGY ,SURVEYS ,INTERPROFESSIONAL relations ,COMMUNICATION ,THEMATIC analysis ,DATA analysis software ,MEDICAL education - Abstract
Purpose: Sharing and developing digital educational resources and open educational resources has been proposed as a way to harmonize and improve clinical pharmacology and therapeutics (CPT) education in European medical schools. Previous research, however, has shown that there are barriers to the adoption and implementation of open educational resources. The aim of this study was to determine perceived opportunities and barriers to the use and creation of open educational resources among European CPT teachers and possible solutions for these barriers. Methods: CPT teachers of British and EU medical schools completed an online survey. Opportunities and challenges were identified by thematic analyses and subsequently discussed in an international consensus meeting. Results: Data from 99 CPT teachers from 95 medical schools were analysed. Thirty teachers (30.3%) shared or collaboratively produced digital educational resources. All teachers foresaw opportunities in the more active use of open educational resources, including improving the quality of their teaching. The challenges reported were language barriers, local differences, lack of time, technological issues, difficulties with quality management, and copyright restrictions. Practical solutions for these challenges were discussed and include a peer review system, clear indexing, and use of copyright licenses that permit adaptation of resources. Conclusion: Key challenges to making greater use of CPT open educational resources are a limited applicability of such resources due to language and local differences and quality concerns. These challenges may be resolved by relatively simple measures, such as allowing adaptation and translation of resources and a peer review system. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
10. Harmonizing and improving European education in prescribing: An overview of digital educational resources used in clinical pharmacology and therapeutics.
- Author
-
Bakkum, Michiel J., Tichelaar, Jelle, Papaioannidou, Paraskevi, Likic, Robert, Sanz Alvarez, Emilio J., Christiaens, Thierry, Costa, João N., Mačiulaitis, Romaldas, Dima, Lorena, Coleman, Jamie, Richir, Milan C., Agtmael, Michiel A., Atanasova, Ivanka, Ganeva, Maria, Gatchev, Emil, Kostadinova, I. I., Mimica Matanovic, S., Vitezic, D, Greta, Wozniak, and Kmonickova, E.
- Subjects
EDUCATIONAL resources ,SIMULATED patients ,MEDICAL schools ,MEDICAL education ,TEACHER-principal relationships ,PHARMACOLOGY - Abstract
Aim: Improvement and harmonization of European clinical pharmacology and therapeutics (CPT) education is urgently required. Because digital educational resources can be easily shared, adapted to local situations and re‐used widely across a variety of educational systems, they may be ideally suited for this purpose. Methods: With a cross‐sectional survey among principal CPT teachers in 279 out of 304 European medical schools, an overview and classification of digital resources was compiled. Results: Teachers from 95 (34%) medical schools in 26 of 28 EU countries responded, 66 (70%) of whom used digital educational resources in their CPT curriculum. A total of 89 of such resources were described in detail, including e‐learning (24%), simulators to teach pharmacokinetics and/or pharmacodynamics (10%), virtual patients (8%), and serious games (5%). Together, these resources covered 235 knowledge‐based learning objectives, 88 skills, and 13 attitudes. Only one third (27) of the resources were in‐part or totally free and only two were licensed open educational resources (free to use, distribute and adapt). A narrative overview of the largest, free and most novel resources is given. Conclusion: Digital educational resources, ranging from e‐learning to virtual patients and games, are widely used for CPT education in EU medical schools. Learning objectives are based largely on knowledge rather than skills or attitudes. This may be improved by including more real‐life clinical case scenarios. Moreover, the majority of resources are neither free nor open. Therefore, with a view to harmonizing international CPT education, more needs to be learned about why CPT teachers are not currently sharing their educational materials. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
11. Kliniškai reikšmingi su nepalankia vaistų tarpusavio sąveika susiję nepageidaujami reiškiniai gydant depresiją: pilotinis tyrimas.
- Author
-
ALEKNIENĖ, Loreta, ALEKNA, Vytautas, MAČIULAITIS, Romaldas, and ADOMAITIENĖ, Virginija
- Published
- 2019
12. Appropriate antibiotic prescribing among final-year medical students in Europe.
- Author
-
van der Voort, Tim, Brinkman, David J., Benemei, Silvia, Böttiger, Ylva, Chamontin, Bernard, Christiaens, Thierry, Likic, Robert, Mačiulaitis, Romaldas, Marandi, Toomas, Monteiro, Emilia C., Papaioannidou, Paraskevi, Pers, Yves M., Pontes, Caridad, Raskovic, Aleksandar, Regenthal, Ralf, Sanz, Emilio J., Wilson, Kurt, Tichelaar, Jelle, and van Agtmael, Michiel A.
- Subjects
- *
MEDICAL students , *SIMULATED patients , *PROBLEM-based learning , *COMMUNITY-acquired pneumonia , *MEDICAL schools , *ASSESSMENT of education - Abstract
• European medical students have poor antimicrobial pharmacotherapeutic skills. • Student prescriptions are highly heterogeneous and often contain errors. Little is known about undergraduate education on antibiotic prescribing in Europe and even less about the antibiotic prescribing skills of nearly-graduated medical students. This study aimed to evaluate the antibiotic prescribing skills of final-year medical students across Europe and the education they received during medical training. In a cross-sectional study, final-year medical students from 17 medical schools in 15 European countries were asked to prescribe for two written case reports of infectious diseases (acute bronchitis and community-acquired pneumonia). The appropriateness of antimicrobial therapy was determined using a scoring form based on local guidelines. Teachers from each medical school were asked to complete a standardised questionnaire about the teaching and assessment of undergraduate education on antibiotic use. In total, 856 final-year medical students (95.6%) completed the assessment and 16 teachers (94.1%) completed the questionnaire. Overall, 52.7% (range 26–83%) of the 1.683 therapies prescribed were considered appropriate. The mean number of contact hours for undergraduate education on antimicrobials was 25.6 (range 2–90). Differences in education styles were found to have a significant impact on students' performance, with a problem-based learning style being associated with more appropriate antimicrobial prescribing than a traditional learning style (46.0% vs. 22.9%; P < 0.01). Although there are differences between medical schools, final-year medical students in Europe lack prescribing skills for two common infectious diseases, possibly because of inadequate undergraduate education on antibiotic use and general prescribing. To improve students' skills, interactive teaching methods such as prescribing for simulated and real patients should be used. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.